Last reviewed · How we verify
NCT04896203: EDGAR
Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease
trial testing rotational thromboelastometry in Inflammatory Bowel Diseases in 50 participants. Status unknown.
15 December 2021
Quick facts
| Lead sponsor | Hospital Universitario La Paz |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 18 November 2020 |
| Primary completion | 15 December 2021 |
| Estimated completion | 15 February 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- rotational thromboelastometry
Conditions studied
- Inflammatory Bowel Diseases — all drugs for Inflammatory Bowel Diseases →
- Thrombosis — all drugs for Thrombosis →
- Blood Coagulation Disorder — all drugs for Blood Coagulation Disorder →
Sponsor
Hospital Universitario La Paz
Who can join
18 and older, any sex, with Inflammatory Bowel Diseases or Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Descriptive study, in which the haemostatic profile of ambulatory patients with IBD will be analyzed by means of ROTEM and other techniques, such as the thrombin generation test and the study of platelet function by flow cytometry.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04896203
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of rotational thromboelastometry
Trials testing the same drug.
- NCT04610853 — Rotational Thromboelastometry Versus DIC Score in Sepsis · completed
Other recruiting trials for Inflammatory Bowel Diseases
Currently open trials in the same condition.
- NCT07520747 — A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea · recruiting
- NCT07349472 — Pentoxifylline in Patients With Ulcerative Colitis · Phase 2 · recruiting
- NCT07033208 — Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance · NA · recruiting
- NCT06842316 — Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases · recruiting
- NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting
Other Hospital Universitario La Paz trials
Trials by the same sponsor.
- NCT07479927 — Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Alloge · NA · recruiting
- NCT07260643 — SiLaC Laser Technique for Pilonidal Sinus - La Paz Cohort Study. · not yet recruiting
- NCT07203664 — Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prop · Phase 4 · not yet recruiting
- NCT07023601 — International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First · NA · enrolling by invitation
- NCT03086850 — Long-term Effect of the Physical Activity Promotion on the Clinical Characteristics and Vascular Risk in Patients With M · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04896203 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitario La Paz
- Last refreshed: 23 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04896203.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing